SCHEMBL6930783

SCHEMBL6930783

Cn1c(CCl)nc2ncccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
RXFP1 Q9HBX9 1/20 0.45
PDE10A Q9Y233 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
FEN1 P39748 1/20 0.41
IDO1 P14902 6/20 0.40
HDAC6 Q9UBN7 2/20 0.40
BRD4 O60885 1/20 0.38
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107381 0.79 IDO1 (0.45) PDE4APDE4BPDE4CPDE4DRXFP1
SCHEMBL1161498 0.78 HDAC6 (0.64) PDE4APDE4BPDE4CPDE4DRXFP1
SCHEMBL29571733 0.78 HDAC6 (0.64) PDE4APDE4BPDE4CPDE4DRXFP1
SCHEMBL6931699 0.77 KDM4E (0.41) PDE4APDE4BPDE4CPDE4DPDE10A
SCHEMBL13150845 0.77 IDO1 (0.48) PDE4APDE4BPDE4CPDE4DRXFP1
SCHEMBL1462732 0.72 KMT2A (0.50) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL6927584 0.71 HDAC6 (0.43) PDE10AKDM4EALOX15TSHRTDP1
SCHEMBL6929561 0.71 HDAC6 (0.43) PDE10AKDM4EALOX15TSHRTDP1
SCHEMBL12857748 0.69 IDO1 (0.51) PDE4APDE4BPDE4CPDE4DRXFP1
SCHEMBL6512906 0.68 PDE4A (0.86) PDE4APDE4BPDE4CPDE4DRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed